The head of several health organizations in Bucks County was recently named as a top leader by a major business publication.

Louis P. Kassa III, the chief executive officer of the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center, was recently chosen by the Philadelphia Business Journal for its Power 101 list, which is being released this week.

Kassa became named CEO of the organizations on July 1, succeeding co-founder Timothy M. Block. In 2019, Dr. Block was named by the Philadelphia Business Journal to the same list.

The magazine noted that Lou Kassa not only led a major expansion at the PABC’s Doylestown campus and attracted new companies nationally, he partnered with Brandywine Realty Trust to open B+labs at Cira Centre in Philadelphia last year.

“Lou’s selection doesn’t surprise me, given the extraordinarily beneficial impact that he’s had on the Pennsylvania Biotech Center, plus the life sciences community in the region,” Block said.

“He’s an international authority on biotechnology entrepreneurship and incubators. The creation of B+labs, the PABC’s growth and Lou’s outreach across the country are extremely impressive. He’s been instrumental in bringing innovators and technology from the San Francisco Bay Area, Boston and North Carolina to Bucks County and Philadelphia.”

The PABC has nearly 100 member companies, mostly small to mid-size science, research and pharmaceutical companies. Nearly 50 of those companies have operations on the Doylestown campus.

It is home to the Hepatitis B Foundation, which operates globally, and the Blumberg Institute, which is the Foundation’s research arm. PABC companies have produced drugs approved by the U.S. Food and Drug Administration and medical devices, and a recent economic study found that the PABC’s economic impact exceed $7.3 billion during the period 2016-2021.

Learn more about the CEO at hepb.org.

_____